World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
59453
World Ranking
16852
National Ranking
8447

Andrew Farb publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrew Farb sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 237 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andrew Farb D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew Farb sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andrew Farb is affiliated with the US Food and Drug Administration in the United States. Their research encompasses a range of topics within medicine, with a notable focus on cardiology and cardiovascular medicine as well as intersections with economics and health policy.

Farb's publication record includes influential work in multiple areas. Their research covers topics such as health systems, economic evaluations, and quality of life; pharmaceutical economics and policy; peripheral artery disease management; coronary interventions and diagnostics; antiplatelet therapy and cardiovascular diseases; acute myocardial infarction research; and mechanical circulatory support devices.

Frequent co-authors collaborating with Farb include:

  • Mitchell W. Krucoff
  • Eric A. Secemsky
  • Misti Malone
  • Michelle E. Tarver
  • Robert W. Yeh

The primary venues where Farb's work has been published are:

  • Circulation
  • Journal of the American College of Cardiology
  • JAMA Cardiology
  • American Heart Journal
  • Cardiovascular Revascularization Medicine

Selected recent papers authored or co-authored by Andrew Farb include:

  • Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations, 2021, Circulation
  • Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium, 2023, Circulation
  • Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC), 2023, Circulation
  • Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI, 2020, Journal of the American College of Cardiology
  • Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock, 2023, JAMA Cardiology

Their research integrates clinical trial design, cardiovascular device assessment, and pharmacological therapy strategies, frequently addressing topics at the intersection of cardiology and health economics. This interdisciplinary approach reflects Farb's involvement in both clinical and policy aspects of cardiovascular health care.

Main fields of study identified in Farb's body of work are Medicine and Economics, Econometrics, and Finance. Within these, subfields include Economics and Econometrics, Cardiology and Cardiovascular Medicine, Surgery, Public Health, Environmental and Occupational Health, and Pulmonary and Respiratory Medicine.

Best Publications

  • Lessons From Sudden Coronary Death A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions

    Renu Virmani;Frank D. Kolodgie;Allen P. Burke;Andrew Farb

  • From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

    Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells

  • Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk

    Michael Joner;Aloke V. Finn;Andrew Farb;Erik K. Mont

  • Pathology of the Vulnerable Plaque

    Renu Virmani;Allen P. Burke;Andrew Farb;Frank D. Kolodgie

  • Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly

    Allen P. Burke;Andrew Farb;Gray T. Malcom;You-hui Liang

  • Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?

    Renu Virmani;Giulio Guagliumi;Andrew Farb;Giuseppe Musumeci

  • Intraplaque hemorrhage and progression of coronary atheroma.

    Frank D Kolodgie;Herman K Gold;Allen P Burke;David R Fowler

  • Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

    Andrew Farb;Allen P Burke;Anita L Tang;Youhui Liang

  • Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk

    Philip Urban;Roxana Mehran;Roisin Colleran;Dominick J. Angiolillo

  • Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression.

    Allen P. Burke;Frank D. Kolodgie;Andrew Farb;Deena K. Weber

  • Pathology of Acute and Chronic Coronary Stenting in Humans

    Andrew Farb;Giuseppe Sangiorgi;Andrew J. Carter;Virginia M. Walley

  • The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes

    Frank D. Kolodgie;Allen P. Burke;Andrew Farb;Herman K. Gold

  • 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

    Karen A. Hicks;James E. Tcheng;Biykem Bozkurt;Bernard R. Chaitman

  • Morphological Predictors of Restenosis After Coronary Stenting in Humans

    Andrew Farb;Deena K. Weber;Frank D. Kolodgie;Allen P. Burke

  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    Hector M. Garcia-Garcia;Eugène P. McFadden;Andrew Farb;Roxana Mehran

  • Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis

    Allen P. Burke;Frank D. Kolodgie;Andrew Farb;Deena Weber

  • Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans

    Andrew Farb;Allen P. Burke;Frank D. Kolodgie;Renu Virmani

  • Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics. A Postmortem Study

    Allen P. Burke;Frank D. Kolodgie;Arthur W. Zieske;David R. Fowler

  • Vulnerable plaque: the pathology of unstable coronary lesions.

    Renu Virmani;Allen P. Burke;Frank D. Kolodgie;Andrew Farb

  • The Pathology of Vulnerable Plaque

    Renu Virmani;Allen P Burke;James T Willerson;Andrew Farb

Frequent Co-Authors

Renu Virmani
Renu Virmani CVPath Institute
Allen P. Burke
Allen P. Burke University of Maryland, Baltimore
Frank D. Kolodgie
Frank D. Kolodgie CVPath Institute
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Donald E. Cutlip
Donald E. Cutlip Beth Israel Deaconess Medical Center
Mitchell W. Krucoff
Mitchell W. Krucoff Duke University
Martin B. Leon
Martin B. Leon Columbia University Medical Center
Jagat Narula
Jagat Narula Icahn School of Medicine at Mount Sinai
Patrick W. Serruys
Patrick W. Serruys University of Galway
Herman K. Gold
Herman K. Gold Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn't always require a traditional medical degree. For those seeking flexible and affordable options, various online programs open doors to vital roles in healthcare.

One popular option is pursuing a cheapest master's in healthcare administration, which can lead to leadership roles in hospitals, clinics, and public health organizations.

Registered nurses wishing to advance can consider enrolling in one of the best online bsn to dnp programs. These programs prepare nurses for top clinical and executive positions without putting their careers on hold.

If your interests lie in medication management and patient care, a 3-year online pharmd can provide the credentials to become a licensed pharmacist swiftly.

Additionally, technology and data-driven roles are expanding. Programs offering rhia certification programs online are ideal for those looking to manage patient records and health information in a digital landscape.

Best Scientists Citing Andrew Farb

Trending Scientists

Recently Published Articles